Table 2 Baseline characteristics of the cohorts
All | GEDAPS 2007 | IDIME | PERCEDIME2 | |
|---|---|---|---|---|
n = 3,041 | n = 1,774 | n = 605 | n = 662 | |
Age, years, mean (SD)** | 60.4 (9.7) | 62.4 (9.0) | 53.6 (9.7) | 61.3 (8.6) |
Gender, men, n (%)* | 1638 (53.8) | 929 (52.3) | 328 (54.2) | 384 (58.0) |
Years since diabetes diagnosis, mean (SD)** | 6.7 (5.5) | 6.3 (5.1) | 6.6 (6.2) | 7.8 (5.8) |
Afroamericans/Afrocaribbeans, n (%)** | 187 (14.8) | 170 (28.1) | 17 (2.6) | |
Tobacco, n (%)** | 435 (14.3) | 317 (17.8) | 4 (0.6) | 116 (17.5) |
BMI, kg/m2, mean (SD) | 30.5 (5.1) | 30.5 (5.1) | 29.9 (5.8) | 30.5 (5.3) |
Waist circumference, cm, mean (SD)* | 100.9 (15.7) | 102.4 (13.2) | 99.7 (7.3) | |
Pulse pressure, mmHg, mean (SD)** | 56.9 (13.1) | 58.2 (12.9) | 55.2 (15.1) | 55.6 (11.4) |
Glycated haemoglobin, %, mean (SD)** | 7.1 (1.6) | 6.8 (1.5) | 7.6 (1.9) | 7.3 (1.3) |
HDL, mg/dL, mean (SD)** | 48.8 (13.3) | 49.8 (13.2) | 47.4 (13.9) | 47.9 (12.7) |
Non-HDL cholesterol** | 146.9 (38.3) | 148.3 (37.1) | 150.9 (43.7) | 140.2 (35.1) |
UAER, mg/gr, mean (SD)* | 29.5 (109.4) | 28.4 (88.2) | 43.6 (185.4) | 24.1 (80.4) |
GFR, mil/min/1.73 m2, mean (SD) | 75.6 (30.4) | 76.29 (32.7) | 74.1 (23.9) | |
Diabetic retinopathy, n (%)** | 325 (10.7) | 238 (13.4) | 52 (8.6) | 55 (8.3) |
Diabetes therapy, n (%)** | ||||
Diet | 560 (18.4) | 408 (23.0) | 63 (10.4) | 89 (13.5) |
OA | 1,063 (34.9) | 751 (42.3) | 223 (36.9) | 89 (13.5) |
OA + Insulin | 504 (16.5) | 150 (8.5) | 80 (13.2) | 274 (41.4) |
Insulin | 192 (6.3) | 110 (6.2) | 48 (7.9) | 34 (5.1) |
OA combined | 722 (23.7) | 355 (20.0) | 191 (31.6) | 176 (26.6) |
Antihypertensive treatment, n (%)** | 1837 (60.4) | 1126 (63.5) | 270 (44.6) | 440 (66.5) |
Dyslipidaemia therapy, n (%)** | 1417 (46.6) | 929 (52.4) | 210 (34.8) | 410 (61.9) |